Distribution of endogenous tumour necrosis factor α in gliomas

Journal of Clinical Pathology

Volumn 50, Issue 7, 1997, Pages 559-562

  Maruno, M ^a,d   Kovach, J S ^c   Kelly, P J ^b   Yanagihara, T ^a  

^a MAYO CLINIC   (United States)

^b Department of Neurologic Surgery ^*

^c Mayo Comprehensive Cancer Center   (United States)

^d OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Endogenous tumour necrosis factor ; Endothelial cells; Glioma cells; Gliomas

Indexed keywords

CD11 ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; NEUROFILAMENT PROTEIN; PROTEIN ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ASTROCYTE; ASTROCYTOMA; CELL INTERACTION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN DETERMINATION;

EID: 0030789842     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.50.7.559     Document Type: Article

References (28)

1. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 1975;72:3666-70.
2. Beutler B, Cerami A. Cachectin (tumor necrosis factor): a macrophage hormone governing cellular metabolism and inflammatory response. Endocr Rev 1988;9:57-66.
3. Hofman FM, Hinton DR. Cytokine interactions in the central nervous system. Reg Immunol 1990/1991;3:268-78.
4. Jaattela M. Biologic activities and mechanisms of action of tumor necrosis factor-α/cachectin. Lab Invest 1991;64:724-42.
5. Brockhaus M, Schoenfeld H-J, Schlaeger E-J, Hunziker W, Lesslauer W, Loetscher H. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA 1990;87: 3127-31.
6. Roessler K, Suchanek G, Breitschopf H, Kitz K, Matula C, Lassmann H, et al. Detection of tumor necrosis factor-α protein nd messenger RNA in human glial brain tumors: comparison of immunohistochemistry with in situ hybridization using molecular probes. J Neurosurg 1995;83:291-7.
7. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumours. Brain Pathol 1993;3:255-68.
8. Benveniste EN, Sparacio SM, Bethea JR. Tumor necrosis factor-α enhances interferon-γ-mediated class II antigen expression on astrocytes. J Neuroimmunol 1986;25:209-19.
9. Lavi E, Suzumura A, Murasko DM, Murray EM, Silberberg DH, Weiss SR. Tumor necrosis factor induces expression of MHC. Class I antigens on mouse astrocytes. J Neuroimmunol 1988;18:245-53.
10. Fontana A, Kristensen F, Dubs R, Gems a D, Weber E. Production of prostaglandin E and an interleukin-1-like factor by cultured astrocytes and C6 glioma cells. J Immunol 1982;129:2413-19.
11. Frei K, Bodmer CS, Schwerdel C, Fontana A. Astrocytes of the brain synthesize interleukin-3-like factors. J Immunol 1985;135:4044-7.
12. Tedeschi B, Barrett JN, Keane RW. Astrocytes produce interferon that enhances the expression of H-2 antigens on a subpopulation of brain cells. J Cell Biol 1986;102:2244-53.
13. Meir EV, Sawamura Y, Diserens AC, Hamou MF, de Tribolet N. Human glioblastoma cells release interleukin 6 in vivo and vitro. Cancer Res 1990;50:6683-8.
14. Chung IY, Benveniste EN. Tumor necrosis factor-α production by astrocytes; induction by lipopolysaccharide, IFN-γ, and IL-1,1β. J Immunol 1990;144:2999-3007.
15. Robbins DS, Shirazi Y, Drysdale BE, Liberman A, Shin HS, Shin ML. Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. J Immunol 1987;139:2593
16. Sawada M, Kondo N, Suzumura A, Marunouchi Tohru. Production of tumor necrosis factor-alpha by microglia and astrocytes in culture. Brain Res 1989;491:394-7.
17. Guilian D, Baker TJ, Shin L, Lachman LB. Interleukin-1 of the central nervous system is produced by ameboid microglia. J Exp Med 1986;164:594-604.
18. Maruno M, Yoshimine T, Isaka T, Muhammad AKMG, Nishioka K, Hayakawa T. Cellular targets of exogenous tumour necrosis factor-alpha (TNFα) in human gliomas. Acta Neurochir 1996;138:1437-41.
19. Hofman FM, Hinton DR, Johnson K, Merrill JE. Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 1989;170:607-12.
20. Hofman FM, Hinton DR, Baemayr J, Weil M, Merrill JE. Lymphokines and immunoregulatory molecules in subacute sclerosing panencephalitis. Clin Immunol Immunopathol 1991;58:331-42.
21. Sharief MK, McLean B, Thompson EJ. Elevated serum levels of tumor necrosis factor-α in Guillain-Barre syndrome. Ann Neurol 1993;33:591-6.
22. Guilian D. Ameboid microglia as effectors of inflammation in the central nervous system. J Neurosci Res 1987;18:155-71.
23. Lachman LB, Brown DC, Dinarello CA. Growth-promoting effect of recombinant interleukin 1 and tumor necrosis factor for a human astrocytoma cell line. J Immunol 1987;138:2913-16.
24. Selmaj KW, Farooq M, Norton WT, Raine CS, Brosnan CF. Proliferation of astrocytes in vitro in response to cytokines. A primary role for the tumor necrosis factor. J Immunol 1990;144:129-35.
25. Isaka T, Yoshimine T, Maruno M, Hayakawa T. Morphological effects of tumor necrosis factor-α on the blood vessels in rat experimental brain tumors. Neurol Med Chir (Tokyo) 1996;36:423-7.
26. Brett J, Gerlach H, Nawroth P, Steinberg S, Godman G, Stern D. Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins. J Exp Med 1989;169: 1977-91.
27. Nawroth PP, Stern DM. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 1986;163:740-5.
28. Wong D, Dorovini-Zis K. Upregulation of intercellular adhesion molecule-1 (ICAM-1) expression in primary cultures of human brain microvessel endothelial cells by cytokines and lipopolysaccharide. J Neuroimmunol 1992; 39:11-22.